AU4342000A - Soluble recombinant endostatin and method of making same from (streptomyces sp) - Google Patents

Soluble recombinant endostatin and method of making same from (streptomyces sp)

Info

Publication number
AU4342000A
AU4342000A AU43420/00A AU4342000A AU4342000A AU 4342000 A AU4342000 A AU 4342000A AU 43420/00 A AU43420/00 A AU 43420/00A AU 4342000 A AU4342000 A AU 4342000A AU 4342000 A AU4342000 A AU 4342000A
Authority
AU
Australia
Prior art keywords
streptomyces
making same
soluble recombinant
recombinant endostatin
endostatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43420/00A
Inventor
Charles L. Desanti
William R. Strohl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU4342000A publication Critical patent/AU4342000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
AU43420/00A 1999-04-13 2000-04-12 Soluble recombinant endostatin and method of making same from (streptomyces sp) Abandoned AU4342000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12908499P 1999-04-13 1999-04-13
US60129084 1999-04-13
PCT/US2000/009747 WO2000060945A1 (en) 1999-04-13 2000-04-12 SOLUBLE RECOMBINANT ENDOSTATIN AND METHOD OF MAKING SAME FROM $i(STREPTOMYCES SP)

Publications (1)

Publication Number Publication Date
AU4342000A true AU4342000A (en) 2000-11-14

Family

ID=22438387

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43420/00A Abandoned AU4342000A (en) 1999-04-13 2000-04-12 Soluble recombinant endostatin and method of making same from (streptomyces sp)

Country Status (2)

Country Link
AU (1) AU4342000A (en)
WO (1) WO2000060945A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060839A2 (en) * 2000-02-18 2001-08-23 The United States Of America, As Represented By Secretary Of The Department Of Health And Human Services Method for refolding recombinant endostatin
EP1668129B1 (en) * 2003-08-29 2008-10-29 Children's Medical Center Corporation Anti-angiogenic peptides from the n-terminus of endostatin
US7524811B2 (en) 2003-08-29 2009-04-28 Children's Medical Center Corporation Anti-angiogenic peptides from the N-terminus of endostatin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854205A (en) * 1995-10-23 1998-12-29 The Children's Medical Center Corporation Therapeutic antiangiogenic compositions and methods
NZ321356A (en) * 1995-10-23 1998-11-25 Childrens Medical Center Endostatin and its use in antiangiogenic compositions

Also Published As

Publication number Publication date
WO2000060945A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
AU7478198A (en) Novel polyketide derivatives and recombinant methods for making same
AU3356197A (en) Method of isolating cyclosporins
AU8007000A (en) Integrated forms and method of making such forms
AU4228197A (en) Method and apparatus for initialization of cryptographic terminal
AU6771500A (en) System and method for administering electronic promotions
AU4024395A (en) Cellular speakerphone and method of operation thereof
AU5265798A (en) Implementation instrument and method
AU7700598A (en) Tissue dissociating system and method
AU7616300A (en) Refractory nzp-type structures and method of making and using same
AU9393198A (en) Surgical gas plasma ignition apparatus and method
AU6564398A (en) Wagering system and method of wagering
AU2039601A (en) Rapid deployment countermeasure system and method
AU9106398A (en) Keypads: improved apparatus and method of making
AU7334598A (en) Reactive cellulose and method for making same
AU2297799A (en) System and method for vibro generations
AUPO976797A0 (en) Method and composition (III)
AU5704599A (en) Stent deployment system and method of use
AU4873197A (en) Novel (alpha-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof
AU3492997A (en) Soi-transistor circuitry employing soi-transistors and method of manufacture thereof
AUPO976597A0 (en) Method and composition (I)
AU2762699A (en) Micro-fastening system and method of manufacture
AU1460600A (en) Hydrophilic substrates and method of making same
AU5997398A (en) Radio telephone systems and methods of operation
AU6270799A (en) Firestarter and method of making same
AU7292300A (en) Synchronization method and synchronization arrangement

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase